PALO ALTO, Calif., April 23, 2025 /PRNewswire/ -- Plume is naming Daniel Herscovici to lead and kickstart the company's next phase of growth as Plume redefines intelligent, adaptive connectivity for ...

This acquisition is part of Shell's strategy to invest in profitable and carbon-competitive oil and gas projects with a strong integrated value chain. Deepening Shell's interest in existing assets ...

SINGAPORE, May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital ...

With Search and Metadata AI Agents at the core, CLEAR ® Content Studio AI Agents are built for the pace of modern storytelling. These specialized, lightweight models work with large language models to ...

The Company reported operating income of 12.12 billion yuan in the first quarter of 2025, up 2.9% year-over-year. Net profit attributable to the parent company rose 54% to 1.41 billion yuan. Net ...

ULTRALOQ's U-Bolt Z-Wave series liberates users from proprietary ecosystems. Leveraging Z-Wave, these locks deliver ultra-low latency, robust privacy, and cloud-free integration with Home Assistant ...

The annual RSAC Conference begins in San Francisco today, bringing together leaders in the cybersecurity space to talk about the path ahead. Companies expected to attend include Microsoft, Alphabet, ...

In February, the company was also recognized with the Silver Award by SolarQuotes—Australia's leading PV installation advisory platform—in its 2025 "Best Batteries in Australia" rankings, placing ...

Yu Xin, Vice President of Appotronics, highlighted the company's evolution in automotive innovation: "We're moving beyond just supplying hardware to co-creating smart mobility experiences. By sharing ...

Petal Ads, Huawei's leading global mobile advertising platform, today successfully hosted the "Think Tank 2025" seminar in ...

To overcome these limitations, Antengene developed ATG-201, a "2+1" CD19 x CD3 TCE, which was evaluated in a series of in vitro studies for binding affinity, T cell dependent cytotoxicity (TDCC) ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...